Sort
34,240 grants matching “atherosclerosis”
Vascular Barrier Leakage in Inflammation
$893,838Sarah Y. Yuan · University Of South Florida · R35 · FY2020 · HL
Vascular Barrier Leakage in Inflammation
$893,838Sarah Y. Yuan · University Of South Florida · R35 · FY2022 · HL
Optimizing Cardiovascular Risk Prediction in HIV
$893,696Virginia Athena Triant · Massachusetts General Hospital · R01 · FY2017 · HL
Cardiac Toxicity in Perinatally HIV-infected Adolescents and Young Adults, a Longitudinal Study
$893,037Steven Edward Lipshultz · Wayne State University · R01 · FY2017 · HL
ARIC Neurocognitive Study (ARIC-NCS)
$892,596Aaron R Folsom · University Of Minnesota · U01 · FY2016 · HL
Eicosanoids, Chronic Kidney Disease Progression, and Associated Cardiovascular Risk
$892,433Susan Cheng · Cedars-Sinai Medical Center · R01 · FY2025 · DK
Eicosanoids, Chronic Kidney Disease Progression, and Associated Cardiovascular Risk
$892,433Susan Cheng · Cedars-Sinai Medical Center · R01 · FY2024 · DK
CLINICAL NUTRITION RESEARCH UNIT
$892,400Alan Chait · University Of Washington · P30 · FY2006 · DK
BASE TITLE: PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND ENDPOINT BIOMARKERS; TASK ORDER TITLE: EFGR AND KRAS VACCINE
$890,873Chinthalapally V. Rao · University Of Oklahoma Hlth Sciences Ctr · N01 · FY2020 · CA
EMR Phenotypes and Community Engaged Genomic Associations
$890,849Christopher G Chute · Mayo Clinic Rochester · U01 · FY2007 · HG
Role of Oxidative Stress and Inflammation in HIV Cardiovascular Risk
$890,691Cecilia M Shikuma · University Of Hawaii At Manoa · R01 · FY2012 · HL
Role of Oxidative Stress and Inflammation in HIV Cardiovascular Risk
$890,587Cecilia M Shikuma · University Of Hawaii At Manoa · R01 · FY2010 · HL
ClinSeq
$890,463Leslie Biesecker · National Human Genome Research Institute · ZIA · FY2010 · HG
Whole-genome sequencing analysis of coronary atherosclerosis and related traits
$890,426Paul Stefan De Vries · University Of Texas Hlth Sci Ctr Houston · R01 · FY2020 · HL
Evaluation of anti-fibrotic and anti-inflammatory semi-synthetic oxysterol, Oxy210, as a therapeutic drug candidate for non-alcoholic steatohepatitis
$889,701Farhad Parhami · Max Biopharma, Inc. · R44 · FY2024 · DK
MRI, Cognitive, Genetic & Biomarker Precursors of AD & Dementia in Young Adults
$889,503Philip A Wolf · Boston University Medical Campus · R01 · FY2013 · AG
Characterization And Functional Significance Of P450 Arachidonate Epoxygenases
$889,054Darryl C Zeldin · National Institute Of Environmental Health Sciences · ZIA · FY2016 · ES
Endothelial Dysfunction, Biomarkers and Lung Function
$888,821Columbia University Health Sciences · R01 · FY2005 · HL
CARDIOVASCULAR DISEASE IN THE PIMA INDIANS
$888,440Medstar Research Institute · U01 · FY2003 · HL
Mapping the Progression to HFpEF in the Elderly through Longitudinal Changes in Cardiac Function
$888,382Amil M Shah · Brigham And Women'S Hospital · R01 · FY2017 · HL
Animal Models of Diabetic Vascular Disease
$887,043Rockefeller University · U01 · FY2001 · HL
Neurocognitive Impairment Assessment in Symptomatic Carotid  Occlusion Recanalized Endovascularly: NIA SCORE
$886,752David M. Hasan · University Of Iowa · R01 · FY2020 · AG
Chemical analysis of coronary atherosclerosis in patients
$886,751Guillermo J. Tearney · Massachusetts General Hospital · R01 · FY2010 · HL
Effect of lipid modification on PAD
$886,483Baylor College Of Medicine · R01 · FY2003 · HL
Genetic Contribution to Brain Arterial Dilatation and its Role in Cognition and dementia
$886,375Jose Gutierrez · Columbia University Health Sciences · R01 · FY2021 · AG